We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.59B
AUM Growth
+$680M
Cap. Flow
+$262M
Cap. Flow %
3.98%
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
46
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$47.5M
2
MSFT icon
Microsoft
MSFT
+$42.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$37.3M
4
ECL icon
Ecolab
ECL
+$36.9M
5
SBUX icon
Starbucks
SBUX
+$33.8M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$101M
2
PM icon
Philip Morris
PM
+$21.2M
3
META icon
Meta Platforms (Facebook)
META
+$11.4M
4
CELG
Celgene Corp
CELG
+$9.78M
5
MRK icon
Merck
MRK
+$8.94M

Sector Composition

Rank Sector Weight
1 Financials 26.2%
2 Healthcare 18.75%
3 Consumer Discretionary 17.75%
4 Communication Services 14.57%
5 Materials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
51
Teva Pharmaceuticals
TEVA
$40B
$8.31M 0.13%
250,231
-22,819
-8% -$706K
VTRS icon
52
Viatris
VTRS
$20.8B
$7.56M 0.11%
194,639
-19,152
-9% -$735K
EXEL icon
53
Exelixis
EXEL
$14B
$7.27M 0.11%
295,175
-260,283
-47% -$5.51M
TSRO
54
DELISTED
TESARO, Inc.
TSRO
$6.54M 0.1%
46,732
-1,241
-3% -$180K
DVAX
55
DELISTED
Dynavax Technologies
DVAX
$6.45M 0.1%
668,215
+384,133
+135% +$2.49M
KITE
56
DELISTED
Kite Pharma, Inc.
KITE
$6.06M 0.09%
58,443
-2,657
-4% -$217K
EXAS
57
DELISTED
Exact Sciences
EXAS
$5.75M 0.09%
162,710
-28,444
-15% -$878K
CAH icon
58
Cardinal Health
CAH
$54.6B
$5.56M 0.08%
71,382
-23,931
-25% -$1.81M
PODD icon
59
Insulet
PODD
$11.7B
$5.49M 0.08%
107,065
+17,644
+20% +$766K
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.42M 0.08%
96,590
-27,963
-22% -$1.12M
AIMT
61
DELISTED
Aimmune Therapeutics
AIMT
$5.12M 0.08%
248,800
+60,700
+32% +$1.16M
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$2.52B
$4.78M 0.07%
76,927
+18,257
+31% +$1.1M
NVCR icon
63
NovoCure
NVCR
$1.81B
$4.73M 0.07%
+273,600
New +$3.53M
AERI
64
DELISTED
Aerie Pharmaceuticals
AERI
$4.71M 0.07%
89,549
+13,458
+18% +$627K
HZNP
65
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.61M 0.07%
388,284
+57,575
+17% +$716K
KTWO
66
DELISTED
K2M Group Holdings, Inc
KTWO
$4.47M 0.07%
183,577
+9,206
+5% +$205K
DXCM icon
67
DexCom
DXCM
$29.2B
$4.47M 0.07%
244,380
+39,404
+19% +$728K
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$4.14M 0.06%
147,998
-33,552
-18% -$760K
SRPT icon
69
Sarepta Therapeutics
SRPT
$1.62B
$4.1M 0.06%
121,528
+38,793
+47% +$1.26M
ESRX
70
DELISTED
Express Scripts Holding Company
ESRX
$4.01M 0.06%
62,863
-6,632
-10% -$417K
EGRX
71
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.85M 0.06%
48,741
-16,344
-25% -$1.34M
AQN icon
72
Algonquin Power & Utilities
AQN
$4.68B
$3.6M 0.05%
264,000
– –
DERM
73
DELISTED
Dermira, Inc.
DERM
$3.52M 0.05%
120,815
+38,069
+46% +$1.16M
PBYI icon
74
Puma Biotechnology
PBYI
$399M
$3.48M 0.05%
39,834
+6,465
+19% +$362K
CHRS icon
75
Coherus Oncology
CHRS
$222M
$3.47M 0.05%
241,505
+48,618
+25% +$935K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2017 Portfolio in Review

As of Q2 2017, C WorldWide Group held 142 positions worth $6.59B, up 12% from $5.91B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $262M of net new capital in Q2 2017, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Bristol-Myers Squibb: 267,012 shares worth $14.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was HDFC Bank, an estimated $101M trimmed.

  • C WorldWide Group's largest Q2 2017 buy was Bristol-Myers Squibb: 267,012 shares worth $14.9M.
  • C WorldWide Group added most to Visa in Q2 2017, an estimated $47.5M increase.
  • C WorldWide Group's biggest Q2 2017 reduction was HDFC Bank, cutting an estimated $101M.
  • C WorldWide Group fully exited Novadaq Technologies Inc. in Q2 2017, selling an estimated $3.86M.
  • C WorldWide Group's ten largest holdings make up 68% of its $6.59B portfolio in Q2 2017.
  • C WorldWide Group opened 14 new positions and closed 13 in Q2 2017.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $6.59B.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.